MMC Healthcare operates a WHO-GMP approved manufacturing facility in Chennai, producing pharmaceutical and nutraceutical products across multiple dosage forms including tablets, capsules, liquid orals, and sachets.
With exports to 30+ countries and 300+ formulations, the company is supported by advanced manufacturing technologies, in-house R&D, analytical laboratories, and a highly experienced technical team.
MMC Healthcare has built a strong presence in semi-regulated markets including Sri Lanka, Myanmar, Maldives, and Cambodia through dedicated regional marketing operations and market-specific strategies.
With a growing footprint across Asia, Africa, and CIS regions, the company is targeting 500+ product registrations over the next five years to strengthen its global presence.
MMC Healthcare has expanded into regulated markets with its USA operations and the successful launch of 15 nutraceutical products under the Ketoveyda brand.
With five ANDAs under development for the USA and three filings planned for Canada, the company is strengthening its global presence through regulated market expansion and international product registrations.